An Unusual Outbreak of Parvovirus B19 Infections, France, 2023 to 2024

Overview

Journal Euro Surveill

Specialty Infectious Diseases

Date 2024 Jun 21

PMID 38904112

Authors

Camille dHumieres

Anne Fouillet

Laura Verdurme

Stevens-Boris Lakoussan

Yves Gallien

Catherine Coignard

Marie Hervo

Anne Ebel

Anais Soares

Benoit Visseaux

Bruno Maire

Pierre-Henry Juan

Isabelle Parent du Chatelet

Jean-Paul Guthmann

Julien Durand

Affiliations

Soon will be listed here.

Abstract

From April 2023 to May 2024, an unusual epidemic of parvovirus B19 (B19V) infections occurred in France. The number of B19V IgM-positive serologies was four times higher than in the previous epidemic in 2019. Clinical data from emergency networks corroborated this observation. Morbidity and mortality consequences were observed in children through all data sources. In adults, the increase was only observed in laboratory-confirmed data. Physicians and decisionmakers should be informed in order to better prevent, diagnose and manage at-risk patients.

Citing Articles

Retrospective and Prospective Surveillance and Clinical Presentation of Parvovirus B19 in Veneto, Italy, 2024.

Tonon M, Panaite S, Gentili D, Ferraresso A, Da Re F, Ballarin D Microorganisms. 2025; 13(2).

PMID: 40005795 PMC: 11858032. DOI: 10.3390/microorganisms13020430.

Genotypic Characterization of Human Parvovirus B19 Circulating in the 2024 Outbreak in Tuscany, Italy.

Beligni G, Alessandri G, Cusi M Pathogens. 2025; 14(2).

PMID: 40005498 PMC: 11858505. DOI: 10.3390/pathogens14020121.

Fulminant parvovirus B19 myocarditis in infants -report of three post-pandemic cases.

Wahjudi T, Nitsch A, Sperhake J, Hoeger P Eur J Clin Microbiol Infect Dis. 2025; .

PMID: 39961949 DOI: 10.1007/s10096-025-05072-1.

Seroepidemiology (2018-2024) and epidemic spread of an emerging human parvovirus B19 genotype 1 (subtype 1a2) variant in Hungary, 2023/2024.

Toth F, Moser T, Boros A, Balazs B, Takats K, Pankovics P Arch Virol. 2025; 170(2):45.

PMID: 39893614 PMC: 11788230. DOI: 10.1007/s00705-025-06228-2.

Clinical Features of Human Parvovirus B19-Associated Encephalitis Identified in the Dakar Region, Senegal, and Viral Genome Characterization.

Seye A, Top F, Mbanne M, Diagne M, Faye O, Sall A Viruses. 2025; 17(1).

PMID: 39861900 PMC: 11769063. DOI: 10.3390/v17010111.

References

Nordholm A, Moller F, Fischer Ravn S, Flink Sorensen L, Moltke-Prehn A, Elskaer Mollerup J . Epidemic of parvovirus B19 and disease severity in pregnant people, Denmark, January to March 2024. Euro Surveill. 2024; 29(24). PMC: 11177569. DOI: 10.2807/1560-7917.ES.2024.29.24.2400299. View

Meyer Sauteur P, Beeton M . Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions. Lancet Microbe. 2023; 5(2):e100-e101. DOI: 10.1016/S2666-5247(23)00344-0. View

Mor O, Wax M, Arami S, Yitzhaki M, Kriger O, Erster O . Parvovirus B19 Outbreak in Israel: Retrospective Molecular Analysis from 2010 to 2023. Viruses. 2024; 16(3). PMC: 10974090. DOI: 10.3390/v16030480. View

Akiner M, Demirci B, Babuadze G, Robert V, Schaffner F . Spread of the Invasive Mosquitoes Aedes aegypti and Aedes albopictus in the Black Sea Region Increases Risk of Chikungunya, Dengue, and Zika Outbreaks in Europe. PLoS Negl Trop Dis. 2016; 10(4):e0004664. PMC: 4846050. DOI: 10.1371/journal.pntd.0004664. View

Cohen R, Ashman M, Taha M, Varon E, Angoulvant F, Levy C . Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?. Infect Dis Now. 2021; 51(5):418-423. PMC: 8114587. DOI: 10.1016/j.idnow.2021.05.004. View

Messacar K, Baker R, Park S, Nguyen-Tran H, Cataldi J, Grenfell B . Preparing for uncertainty: endemic paediatric viral illnesses after COVID-19 pandemic disruption. Lancet. 2022; 400(10364):1663-1665. PMC: 9282759. DOI: 10.1016/S0140-6736(22)01277-6. View

Fourgeaud J, Allali S, Toubiana J, Pinhas Y, Frange P, Leruez-Ville M . Post-COVID-19 pandemic outbreak of severe Parvovirus B19 primary infections in Paris, France: 10-year interrupted time-series analysis (2012-2023). J Clin Virol. 2023; 167:105576. DOI: 10.1016/j.jcv.2023.105576. View

Molenaar-de Backer M, Hogema B, Koppelman M, van de Laar T, Slot E, Zaaijer H . Lower Incidence of Parvovirus-B19 Infections in Dutch Blood Donors during SARS-CoV-2 Pandemic. Microbiol Spectr. 2021; 9(2):e0025321. PMC: 8565513. DOI: 10.1128/Spectrum.00253-21. View

Jacquot R, Gerfaud-Valentin M, Mekki Y, Billaud G, Jamilloux Y, Seve P . [Parvovirus B19 infections in adults]. Rev Med Interne. 2022; 43(12):713-726. DOI: 10.1016/j.revmed.2022.08.005. View

10.

Guillet M, Bas A, Lacoste M, Ricard C, Visse C, Barlet V . New atypical epidemiological profile of parvovirus B19 revealed by molecular screening of blood donations, France, winter 2023/24. Euro Surveill. 2024; 29(21). DOI: 1560-7917.ES.2024.29.21.2400253. View

11.

Iro M, Goldacre M, Morris E, Goldacre R . Hospital admissions for group A streptococcal infections in England: current rates and historical perspective. Lancet Infect Dis. 2023; 23(9):e326-e327. DOI: 10.1016/S1473-3099(23)00428-0. View

12.

Thiam M, Pontais I, Forgeot C, Pedrono G, Paget L, Fouillet A . Syndromic surveillance: A key component of population health monitoring during the first wave of the COVID-19 outbreak in France, February-June 2020. PLoS One. 2022; 17(2):e0260150. PMC: 8830636. DOI: 10.1371/journal.pone.0260150. View